Susquehanna International Group’s Genesis Healthcare, Inc. GEN Stock Holding History

Susquehanna International Group’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-24,960	Closed	-$21K	–	11346
2020 Q1	$21K	Buy	+24,960	New	+$35.7K	﹤0.01%	9930
2019 Q4	–	Sell	-37,386	Closed	-$41K	–	11063
2019 Q3	$41K	Buy	37,386 +2,641	+8%	+$3.05K	﹤0.01%	9837
2019 Q2	$43K	Buy	+34,745	New	+$44.2K	﹤0.01%	9877
2019 Q1	–	Sell	-16,860	Closed	-$25K	–	10268
2018 Q4	$20K	Sell	16,860 -43,922	-72%	-$65.2K	﹤0.01%	8682
2018 Q3	$82K	Buy	+60,782	New	+$96.3K	﹤0.01%	8672
2017 Q3	–	Sell	-13,313	Closed	-$23K	–	9957
2017 Q2	$23K	Buy	+13,313	New	+$28.3K	﹤0.01%	9005
2017 Q1	–	Sell	-36,967	Closed	-$133K	–	10402
2016 Q4	$157K	Buy	+36,967	New	+$122K	﹤0.01%	8821
2015 Q4	–	Sell	-15,155	Closed	-$93K	–	10212
2015 Q3	$93K	Buy	15,155 +4,628	+44%	+$31.4K	﹤0.01%	9175
2015 Q2	$69K	Sell	10,527 -1,950	-16%	-$13.2K	﹤0.01%	9798
2015 Q1	$89K	Buy	+12,477	New	+$94.1K	﹤0.01%	9004

Other funds holding GEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group's GEN Position: Q2 2020 in Review

Susquehanna International Group sold out of Genesis Healthcare, Inc. (GEN) in Q2 2020, closing a stake of 24,960 shares — an estimated $21K sold.

Susquehanna International Group first reported a position in GEN in Q1 2015 and held it in 10 quarters. The position peaked at $157K in Q4 2016. 58 funds tracked by Wall St. Rank hold GEN as of Q2 2020.

Susquehanna International Group reported no remaining Genesis Healthcare, Inc. position as of Q2 2020 after selling out during the quarter.
Susquehanna International Group sold 24,960 Genesis Healthcare, Inc. shares in Q2 2020, an estimated $21K.
Susquehanna International Group first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 10 quarters.
Susquehanna International Group's Genesis Healthcare, Inc. position peaked at $157K in Q4 2016.
58 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.